MERIDIAN VENTURE PARTNERS II LP - 16 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: 10%+ Owner
Issuer ticker: ANIP
Reported as of: 16 Aug 2023
Net transaction value: -$11,700,000
SEC form: 4
Accepted by SEC: 16 Aug 2023, 20:00:20 UTC
Prior SEC filing: 02 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert E. Brown, Jr.

Key filing fact

MERIDIAN VENTURE PARTNERS II LP filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 16 Aug 2023.

Key facts

This page summarizes MERIDIAN VENTURE PARTNERS II LP's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Aug 2023, 20:00.

Change

Previous filing in this sequence was filed on 02 Dec 2022.
Current net transaction value: -$11,700,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Sale

Transaction value: $11,700,000
Shares: -200,000
Change %: -9.9%
Price: $58.50
Shares after: 1,819,259
Date: 16 Aug 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

MERIDIAN VENTURE PARTNERS II LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.